ESC Premium Access

Implantable devices: what's new?

Event: ESC Congress 2018
Topic: Device Therapy
Session type: Abstract Sessions
Date: 27 August 2018
Time: 11:00 - 12:30

Congress Session

6 presentations in this session

Risk of atrial fibrillation after pm implantation: a nationwide danish registry-based follow-up study

Speaker: Doctor B. Tayal (Aalborg, DK)

Impact of anti-coagulation therapy on in-hospital outcomes of CRT patient treated with transvenous lead extraction

Speaker: Doctor F. Regoli (Lugano, CH)

Transseptal endocardial left ventricular lead implantation is an effective and feasible method and exerts long lastig beneficial haemodynamical effects after failed CRT implantation

Speaker: Professor L. Geller (Budapest, HU)

The acute extravascular defibrillation, pacing and electrogram (ASD2) study results

Speaker: Professor B. Merkely (Budapest, HU)

Use of 3D printed models as a tool to obtain feedback on delivery tool design for a novel extravascular ICD implant procedure

Speaker: Ms B. Portway (Mounds View, US)

Lead material retention and clinical outcomes in patients undergoing transvenous lead extraction

Speaker: Doctor A. Hussein (Cleveland, US)

6 speakers from this session

Doctor Bhupendar Tayal

Aalborg University Hospital, Aalborg (Denmark)
0 follower

Doctor Francois Regoli

Fondazione Cardiocentro Ticino, Lugano (Switzerland)
0 follower

Professor Laszlo Alajos Geller

Semmelweis University, Cardiovascular Center, Budapest (Hungary)
1 presentation
0 follower

Professor Bela Merkely

Semmelweis University Heart and Vascular Center, Budapest (Hungary)
8 presentations
0 follower

Ms Bridget Portway

Medtronic, Mounds View (United States of America)
0 follower

Doctor Ayman Hussein

Cleveland Clinic, Cleveland (United States of America)
0 follower

This platform is supported by

logo Novo Nordisk